Sign In
Buy NAD
$11.78
-0.0700 (-0.591%)
At Close: Jun 03, 2026
Tru2u.health Expands Digital Health Platform with the Addition of NAD+ - The Cellular Energy Molecule Transforming Modern Wellness
08:00am, Wednesday, 29'th Apr 2026
Lake Oswego, Oregon--(Newsfile Corp. - April 29, 2026) - Functional Brands Inc. (NASDAQ: MEHA), a leading innovator in wellness and performance products, today announced a significant expansion of its
Why Low Tax Muni Bonds Belong In Your Retirement Portfolio In 2026
07:35am, Wednesday, 29'th Apr 2026
Municipal bonds offer tax-exempt income with lower default risk than similarly rated corporate bonds, making them attractive for higher-income investors. Long-duration munis are well-positioned to ben
Nuveen Quality Municipal Income Fund (NYSE:NAD) Share Price Crosses Below Two Hundred Day Moving Average – Here’s What Happened
04:52am, Tuesday, 21'st Apr 2026
Nuveen Quality Municipal Income Fund (NYSE: NAD - Get Free Report)'s share price passed below its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $11.96 and
A Pair Trade Opportunity By Nuveen Quality Municipal Income Funds
05:35pm, Monday, 06'th Apr 2026
Nuveen Quality Municipal Income Fund (NAD) and Nuveen AMT-Free Quality Municipal Income Fund (NEA) are nearly identical municipal bond CEFs with highly correlated NAVs. Currently, NEA trades at a 120
Nuveen Quality Municipal Income Fund (NYSE:NAD) Shares Pass Below Two Hundred Day Moving Average – Time to Sell?
02:51am, Saturday, 28'th Mar 2026
Shares of Nuveen Quality Municipal Income Fund (NYSE: NAD - Get Free Report) passed below its two hundred day moving average during trading on Friday. The stock has a two hundred day moving average of
Bramshill Sells Nuveen Quality Municipal Income Fund
08:33am, Tuesday, 10'th Mar 2026
Nuveen Quality Municipal Income Fund invests in high-grade municipal bonds, aiming to deliver federally tax-exempt income for shareholders.
LOS ANGELES--(BUSINESS WIRE)---- $NAGE #ClinicalResearch--Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of health
Niagen Bioscience Expands HSA/FSA Access for Tru Niagen®, the Leading NAD+ Supplement in the U.S.*
08:34am, Thursday, 15'th Jan 2026
LOS ANGELES--(BUSINESS WIRE)---- $NAGE #Biotech--Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging,
NAD: Entirely Normal Return, We Can Do Better In Munis
08:40pm, Tuesday, 23'rd Dec 2025
Nuveen Quality Muni Income Fund delivers a 4.7% true yield via high-credit, long-tenor municipal bonds, but faces significant interest rate risk. NAD's strategy emphasizes credit quality over yield, r
LOS ANGELES--(BUSINESS WIRE)---- $NAGE #Biotech--Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging,
AT&T Files Lawsuit Against NAD to Defend Its Right to Make Truthful Claims About Competitors
12:21pm, Thursday, 30'th Oct 2025
DALLAS , Oct. 30, 2025 /PRNewswire/ -- We're committed to telling the truth about the competition's misleading claims Key Takeaways: In the last four years, the National Advertising Division (NAD) has
NAD: Recent Double-Digit Pop, But Still Offering Value
08:16am, Thursday, 30'th Oct 2025
Nuveen Quality Muni Income Fund offers high-quality municipal bond exposure with a focus on tax-exempt income. Equities are expensive, and hedges make sense at this point. With a discount to its under
NAD: High Leverage Will Limit Growth
12:00pm, Monday, 27'th Oct 2025
Nuveen Quality Muni Income Fund provides exposure to a diverse range of municipal securities. The fund offers a high dividend yield above 7.1% and monthly payouts, which makes it an attractive choice
National Advertising Division Finds Certain Reus Cata-Kor NAD+ Claims Supported; Recommends Others Be Modified or Discontinued
03:00pm, Monday, 13'th Oct 2025
In a challenge brought by Niagen Bioscience Inc., BBB National Programs' National Advertising Division found certain Reus Research LLC claims for its
AboutNADⓇ Debuts as the Leading Online Resource for Scientific Advancements in NAD+
08:32am, Tuesday, 16'th Sep 2025
LOS ANGELES--(BUSINESS WIRE)---- $NAGE #AboutNAD--Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging,
